12-9688054-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013269.6(CLEC2D):c.325G>A(p.Asp109Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,609,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_013269.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000807 AC: 2AN: 247802Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134130
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1457360Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 725008
GnomAD4 genome AF: 0.000118 AC: 18AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.325G>A (p.D109N) alteration is located in exon 3 (coding exon 3) of the CLEC2D gene. This alteration results from a G to A substitution at nucleotide position 325, causing the aspartic acid (D) at amino acid position 109 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at